131 related articles for article (PubMed ID: 18223555)
1. Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas.
Petri BJ; Speel EJ; Korpershoek E; Claessen SM; van Nederveen FH; Giesen V; Dannenberg H; van der Harst E; Dinjens WN; de Krijger RR
Mod Pathol; 2008 Apr; 21(4):407-13. PubMed ID: 18223555
[TBL] [Abstract][Full Text] [Related]
2. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
Herfarth KK; Wick MR; Marshall HN; Gartner E; Lum S; Moley JF
Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
[TBL] [Abstract][Full Text] [Related]
3. [Distinction between benign and malignant pheochromocytomas].
Liu TH; Chen YJ; Wu SF; Gao J; Jiang WJ; Lu ZH; Guan J; Wei SZ; Luo YF; Cao JL; Wan JW
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):198-202. PubMed ID: 15256107
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
6. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan.
Reincke M; Wachenfeld C; Mora P; Thumser A; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3636-8. PubMed ID: 8855814
[TBL] [Abstract][Full Text] [Related]
8. Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.
Dannenberg H; Speel EJ; Zhao J; Saremaslani P; van Der Harst E; Roth J; Heitz PU; Bonjer HJ; Dinjens WN; Mooi WJ; Komminoth P; de Krijger RR
Am J Pathol; 2000 Aug; 157(2):353-9. PubMed ID: 10934139
[TBL] [Abstract][Full Text] [Related]
9. Microarray-based comparative genomic hybridization of pheochromocytoma cell lines from neurofibromatosis knockout mice reveals genetic alterations similar to those in human pheochromocytomas.
Powers JF; Tischler AS; Mohammed M; Naeem R
Cancer Genet Cytogenet; 2005 May; 159(1):27-31. PubMed ID: 15860353
[TBL] [Abstract][Full Text] [Related]
10. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair.
Blanes A; Sanchez-Carrillo JJ; Diaz-Cano SJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1150-8. PubMed ID: 16394087
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.
Yana I; Nakamura T; Shin E; Karakawa K; Kurahashi H; Kurita Y; Kobayashi T; Mori T; Nishisho I; Takai S
Jpn J Cancer Res; 1992 Nov; 83(11):1113-6. PubMed ID: 1483923
[TBL] [Abstract][Full Text] [Related]
12. The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas.
Yoshimoto T; Naruse M; Zeng Z; Nishikawa T; Kasajima T; Toma H; Yamamori S; Matsumoto H; Tanabe A; Naruse K; Demura H
J Endocrinol; 1998 Nov; 159(2):247-55. PubMed ID: 9795365
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of telomerase activity in malignant pheochromocytoma.
Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
[TBL] [Abstract][Full Text] [Related]
14. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
[TBL] [Abstract][Full Text] [Related]
15. Allelic loss of chromosomes 8 and 19 in MENX-associated rat pheochromocytoma.
Shyla A; Hölzlwimmer G; Calzada-Wack J; Bink K; Tischenko O; Guilly MN; Chevillard S; Samson E; Graw J; Atkinson MJ; Pellegata NS
Int J Cancer; 2010 May; 126(10):2362-72. PubMed ID: 19876893
[TBL] [Abstract][Full Text] [Related]
16. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry.
Yuan W; Wang W; Cui B; Su T; Ge Y; Jiang L; Zhou W; Ning G
Endocr Relat Cancer; 2008 Mar; 15(1):343-50. PubMed ID: 18310300
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic characterization in four pediatric pheochromocytomas and paragangliomas.
Vicha A; Holzerova M; Krepelova A; Musil Z; Prochazka P; Sumerauer D; Kodet R; Eckschlager T; Jarosova M
Pathol Oncol Res; 2011 Dec; 17(4):801-8. PubMed ID: 21461997
[TBL] [Abstract][Full Text] [Related]
20. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
